Page 8 - Connectivity Platform News Today

Masimo Monday, May 17, 2021 3:02PM IST (9:32AM GMT) Researchers Found That Use of Patient SafetyNet with Masimo SET® Pulse Oximetry and Acoustic Repsiratory Rate (RRa®) Monitoring Reduced Nursing Workload Related to Postoperative Respiratory Assessment by More Than 60%   Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of PeriAnesthesia Nursing in which Drs. Mashasi Ishikawa and Atsuhiro Sakamoto at Nippon Medical School in Tokyo evaluated the utility a...

May 11, 2021 healthcaretechnology Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3® Regional Oximetry to aid in monitoring septic shock patients admitted to the ICU.1 O3, av...

Masimo Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality Monday, May 10, 2021 12:50PM IST (7:20AM GMT) Researchers Found That O3 May Help Clinicians Rapidly Assess Circulatory Status in Patients Experiencing Septic Shock and Have Prognostic Value in Mortality Prediction   Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and col...

Share: Masimo (NASDAQ:MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall dHebron University Hospital in Barcelona evaluated the utility of Masimo PVi ® as a noninvasive method of predicting preload responsiveness in patients treated with nasal high-flow (NHF) therapy. They found that PVi may identify preload responders and noted that PVi may therefore be used in the "day-to-day clinical d...

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu and colleagues at the Vall d’Hebron University Hospital in Barcelona evaluated the utility of Masimo PVi® as a noninvasive method of predicting preload responsiveness in patients treated with nasal high-flow (NHF) therapy. They f...

Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARD...

Masimo New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy Monday, March 15, 2021 1:12PM IST (7:42AM GMT)   Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in ...

Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device. The device requires no routine calib...

Press release content from Business Wire. The AP news staff was not involved in its creation. Masimo Monitoring Solutions Promote Newborn and Maternal Safety March 8, 2021 GMT Masimo Newborn Sensor (Photo: Masimo) NEUCHATEL, Switzerland--(BUSINESS WIRE)--Mar 8, 2021-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to meas...

Masimo Announces CE Marking of the Rad-G™ with Temperature Tuesday, March 2, 2021 1:26PM IST (7:56AM GMT)   Neuchatel, Switzerland:   Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ®), and other important parameters alongside clinical-grade, non-contact infrared thermometry. W...